Total raised
$5.0M
Last: Undisclosed 2025-02
Stage
Seed
Founded
2019
Headcount
2
HQ
Petah Tikva, Israel
Sector
Health Tech & Life Sciences
About
Xerient is focused on unmet needs in cancer treatment, particularly in abdominal and gastrointestinal cancers. Xerient is pursuing the development of novel therapeutics and diagnostic technologies that can dramatically improve the survival of these patients.
The company is introducing a portfolio of products that will address hard to treat cancers in the abdominal/GI area, beginning with solutions for pancreatic cancer.
Funding history · 2 rounds · $5.0M total
2025-02
Undisclosed
Undisclosed
2023-07
Undisclosed
$2.1M
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
1 Patents
Tags
gastroenterologycancerpharmaceuticalscancer-therapy